R. Watts

D. Scott, Kazuo Suzuki, H. Hashimoto, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies

D. Scott, R. Watts, S. Lane, 2005 .

Cutaneous vasculitis in a defined population--clinical and epidemiological associations.

D. Scott, R. Watts, C. Grattan, 1998, The Journal of rheumatology.

Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, Z. C. Chiesa Fuxench, R. Luqmani, 2020, Arthritis & Rheumatology.

Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 1.

R. Watts, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.

W. Koldingsnes, R. Luqmani, R. Watts, 2019, Rheumatology.

Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?

R. Watts, 2019, International journal of rheumatic diseases.

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody–associated vasculitis

P. Merkel, R. Luqmani, R. Watts, 2017, Rheumatology.

Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

N. Basu, A. Mahr, L. Flores-Suárez, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.

S. Mackie, A. Macgregor, R. Watts, 2015, Rheumatology.

Classification of ANCA-Associated Vasculitis

R. Watts, I. Khan, 2013, Current Rheumatology Reports.

ANCA vasculitis: to lump or split? Why we should study MPA and GPA separately.

D. Scott, R. Watts, 2012, Rheumatology.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

P. Merkel, C. Kallenberg, E. Matteson, 2011, Arthritis and rheumatism.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?

R. Watts, M. Yates, Task Toyoda, 2022, Current Rheumatology Reports.

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

P. Merkel, A. Judge, J. Robson, 2017, Rheumatology.

Classification and Epidemiology

D. Scott, R. Watts, C. Mukhtyar, 2015 .

Classification of vasculitis: EMA classification using CHCC 2012 definitions

D. Scott, R. Watts, S. Lane, 2013, Annals of the rheumatic diseases.

Use of the CHCC 2012 definitions in the classification of AAV using the EMA algorithm

D. Scott, R. Watts, S. Lane, 2013 .

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis

P. Merkel, C. Kallenberg, E. Matteson, 2011, Annals of the rheumatic diseases.

Incidence of inflammatory polyarthritis in polymyalgia rheumatica: a population-based cohort study

R. Luben, K. Khaw, A. Macgregor, 2018, Annals of the rheumatic diseases.

Retinal vasculometric characteristics and their associations with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Eye Study

A. Rudnicka, S. Barman, R. Luben, 2019, Annals of the rheumatic diseases.

Clinical associations of renal involvement in ANCA-associated Vasculitis.

P. Merkel, G. Mayer, L. Quintana, 2020, Autoimmunity reviews.

Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

D. Scott, Kazuo Suzuki, H. Hashimoto, 2011, Rheumatology.

The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.

D. Scott, A. Macgregor, R. Watts, 2012, Rheumatology.

Herberden Historical Series Alkaptonuria : a 60-yr follow-up

R. Watts, R. Watts, 2007 .

Alkaptonuria: a 60-yr follow-up.

R. Watts, R. Watts, 2006, Rheumatology.

Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with peniciUamine

P. Mathieson, R. Watts, D. Peat, 2005 .

Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.

P. Mathieson, R. Watts, D. Peat, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.

D. Scott, R. Watts, J. Mooney, 2014, Rheumatology.

Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort

P. Merkel, J. Robson, R. Luqmani, 2019, Arthritis & rheumatology.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci strati ﬁ ed by ANCA status

William J. Astle, Kenneth G. C. Smith, C. Wallace, 2019 .

Full Review Classi ﬁ cation, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

N. Basu, A. Mahr, L. Flores-Suárez, 2015 .

Epidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome.

D. Scott, R. Watts, S. Lane, 2002, Cleveland Clinic journal of medicine.

Primary renal vasculitis in Norfolk--increasing incidence or increasing recognition?

D. Scott, R. Watts, S. Lane, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Classification and epidemiology of the vasculitides.

D. Scott, R. Watts, 1997, Bailliere's clinical rheumatology.

2. Epidemiology of giant cell arteritis: a critical review

R. Watts, 2014 .

Rarity of reported cases of vasculitis in Africa: comment on the article by Bae et al.

R. Watts, A. Adebajo, 1999, Arthritis and rheumatism.

Two cases of serious food-borne infection in patients treated with anti-TNF-alpha. Are we doing enough to reduce the risk?

R. Watts, G. Clunie, R. Kent, 2006, Rheumatology.

University of Birmingham Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis

Kenneth G. C. Smith, P. Lyons, R. Watts, 2009 .

Outcomes and compliance with standards of care in anti-neutrophil cytoplasmic antibody–associated vasculitis—insights from a large multiregion audit

Catherine M. McGrath, P. Lanyon, R. Watts, 2018, Rheumatology advances in practice.

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS

J. Isaacs, G. Hale, H. Waldmann, 1992 .

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)

P. Merkel, A. Judge, J. Robson, 2013, Clinical and Experimental Nephrology.

P185 Patient perceptions of physical activity following a diagnosis of giant cell arteritis: a multinational qualitative study

C. Hill, S. Mackie, J. Robson, 2020, Rheumatology.

Impact of caring for someone with a rare rheumatic condition, views from patients and informal carers—the need for cat-like vigilance

R. Watts, J. Mooney, K. Graham, 2019, Rheumatology advances in practice.

Treatment of a case with pooled intravenous immunoglobulin as an alternative to immunosuppression.

L. Ginsberg, R. Watts, F. Hall, 1992, Journal of neurology, neurosurgery, and psychiatry.

Rheumatoid arthritis: Rheumatoid vasculitis—down but not out

R. Watts, 2014, Nature Reviews Rheumatology.

Relaxation therapies in the treatment of psoriasis and possible pathophysiologic mechanisms.

R. Watts, Royce A. Watts, S. Winchell, 1988, Journal of the American Academy of Dermatology.

Pancreatic disease in the autoimmune rheumatic disorders.

D. Isenberg, R. Watts, David A. Isenberg, 1989, Seminars in arthritis and rheumatism.

Vasculitis-aims of therapy. An overview.

D. Scott, C. Pusey, C. Lockwood, 2000, Rheumatology.

Is There Spatial Clustering of ANCA-Associated Vasculitis in the UK?

D. Scott, A. Macgregor, R. Watts, 2009 .

Musculoskeletal and systemic reactions to biological therapeutic agents.

R. Watts, 2000, Current opinion in rheumatology.

FRI0464 Development of the Classification Criteria for GIANT Cell Arteritis in the Diagnostic and Classification Criteria for Vasculitis Study: A Pilot Study Using A Panel Review Methodology

A. Judge, J. Robson, R. Luqmani, 2014 .

Primary Angiitis of the Central Nervous System Vasculitis

D. Scott, R. Watts, 2010 .

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.

D. T. Gray, Janet A. Blood, I. Bruce, 2020, Rheumatology.

For the times they are a-changin'.

R. Watts, S. Cubie, 2004, Rheumatology.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.

D. D'cruz, N. Basu, A. Salama, 2020, Rheumatology.

General Presentation of the Vasculitides

D. Scott, R. Watts, C. Mukhtyar, 2010 .

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

B. Griffiths, A. Morgan, S. Mackie, 2018, Rheumatology.

Early development of new cardiovascular risk factors in the systemic vasculitides.

P. Merkel, C. Klersy, C. Montecucco, 2019, Clinical and experimental rheumatology.

Can prediction models in primary care enable earlier diagnosis of rare rheumatic diseases?

P. Lanyon, R. Watts, F. Pearce, 2018, Rheumatology.

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

Patient Perceptions of Physical Activity After a Diagnosis of Giant Cell Arteritis: Analysis of Multinational Qualitative Data

S. Mackie, J. Robson, E. Hoon, 2021, Arthritis care & research.

O36 Validation of methods to enable national registration for rare autoimmune rheumatic diseases

M. Bythell, B. Griffiths, P. Lanyon, 2020 .

Immunotherapy of rheumatoid arthritis.

J. Isaacs, R. Watts, 1992, Annals of the rheumatic diseases.

The incidence of rheumatoid vasculitis in the Norwich Health Authority.

D. Symmons, D. Scott, D. Carruthers, 1994, British journal of rheumatology.

Dose reduction of etanercept--can we treat more patients using a fixed budget?

R. Watts, G. Clunie, S. Voules, 2003, Rheumatology.

Classification and epidemiology of systemic vasculitis.

D. Scott, R. Watts, D. Scott, 1994, British journal of rheumatology.

IgG4 Related Disease

D. Scott, R. Watts, C. Mukhtyar, 2015 .

The missing picture: blindness in giant cell arteritis.

A. Macgregor, R. Watts, M. Yates, 2015, Clinical and experimental rheumatology.

Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand

C. Frampton, L. Stamp, P. Chapman, 2015, Arthritis Research & Therapy.

Spontaneous fracture of the sternum and sternal tuberculosis.

R. Watts, A. White, E. Paice, 1987, Thorax.

An unusual cause of blindness in Wegener's granulomatosis.

D. Scott, R. Watts, D. O’Gradaigh, 1999, Rheumatology.

Isolated nail fold vasculitis in rheumatoid arthritis.

D. Scott, D. Carruthers, R. Watts, 1995, Annals of the rheumatic diseases.

FAMILIAL EOSINOPHlLIC FASCIITIS AND BREAST CANCER

P. Merry, R. Watts, 1994 .

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

K. Chakravarty, D. Scott, D. D'cruz, 2014, Rheumatology.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

P. Gregersen, C. Wijmenga, J. Barrett, 2015, American journal of human genetics.

Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

D. Scott, David Steven Scott, G. Bentham, 2000, Arthritis and rheumatism.

Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis

William J. Astle, Kenneth G. C. Smith, C. Wallace, 2018, bioRxiv.

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

P. Merkel, A. Judge, J. Robson, 2022, Annals of the Rheumatic Diseases.

2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis

P. Merkel, A. Judge, J. Robson, 2022, Arthritis & rheumatology.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

C. Wijmenga, J. Barrett, B. Lie, 2017, American journal of human genetics.

Necrotizing Fasciitis Mimicking a Ruptured Popliteal Cyst

R. Watts, P. M. Bretland, 1990, Journal of the Royal Society of Medicine.

Copy number, linkage disequilibrium and disease association in the FCGR locus

Tim F. Rayner, Kenneth G. C. Smith, D. Clayton, 2010, Human molecular genetics.

Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake

Kenneth G. C. Smith, N. McGovern, M. Clatworthy, 2008, The Journal of experimental medicine.

Contrasting genetic association of IL2RA with SLE and ANCA – associated vasculitis

Kenneth G. C. Smith, Richard A Watts, Paul A Lyons, 2009, BMC Medical Genetics.

Global epidemiology of vasculitis

J. Burns, G. Hatemi, R. Watts, 2021, Nature Reviews Rheumatology.

ANCA vasculitis: time for a change in treatment paradigm? Not yet.

R. Watts, J. Mooney, E. Ntatsaki, 2011, Rheumatology.

'In one ear and out the other - it's a lot to take in': a qualitative study exploring the informational needs of patients with ANCA-associated vasculitis.

David Steven Scott, F. Poland, D. Scott, 2013, Musculoskeletal care.

Hyperparathyroid bone disease—an unusual and memorable condition

R. Watts, G. Clunie, R. Nightingale, 2006, Annals of the rheumatic diseases.

Oxford Textbook of Rheumatology

J. Isaacs, U. Müller-Ladner, C. Denton, 2013 .

Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis

Kenneth G. C. Smith, P. Lyons, R. Watts, 2009, BMC Medical Genetics.

Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice.

A. Macgregor, R. Watts, M. Yates, 2017, Clinical and experimental rheumatology.

Epidemiology of the Vasculitides

D. Scott, R. Watts, Richard Watts1, 2004, Seminars in respiratory and critical care medicine.

Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.

R. Hubbard, M. Grainge, A. Mahr, 2016, Rheumatology.

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Shigeto Kobayashi, John McLaren, David Jayne, 2010, Annals of the rheumatic diseases.

The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink

Richard A Watts, R. Hubbard, M. Grainge, 2016, Rheumatology.

Pulmonary haemorrhage in ANCA-associated vasculitis.

V. Ravindran, R. Watts, 2010, Rheumatology.

Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44.

J. Beckmann, D. Scott, David Steven Scott, 1999, American journal of human genetics.

Scurvy: MRI appearances.

R. Watts, S. Dubey, S. Karthiga, 2008, Rheumatology.

CUTANEOUS MANIFESTATIONS OF ANCA-ASSOCIATED VASCULITIS

P. Merkel, R. Luqmani, R. Watts, 2016 .

Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis.

D. Scott, R. Watts, S. Lane, 2003, Arthritis and rheumatism.

Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis

Tim F. Rayner, Kenneth G. C. Smith, S. Eyre, 2018, Annals of the rheumatic diseases.

Pulmonary Involvement in Primary Systemic Vasculitides.

P. Merkel, J. Robson, R. Luqmani, 2021, Rheumatology.

Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health

Paul J Thornalley, R. Savage, U. Ahmed, 2015, Scientific Reports.

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

I. Bruce, D. Symmons, P. Macfarlane, 2019, Arthritis & Rheumatology.

Familial eosinophilic fasciitis and breast cancer.

P. Merry, R. Watts, 1994, British journal of rheumatology.

The Immunopathogenesis and Immunotherapy of Autoimmune Disease

G. Kingsley, R. Watts, 1993, Journal of the Royal College of Physicians of London.

Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation

Stephen G. Martin, J. Barrett, A. Morgan, 2015, Arthritis Research & Therapy.

Management of polymyalgia rheumatica

R. Watts, E. Ntatsaki, 2010, BMJ : British Medical Journal.

Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab

R. Watts, G. Clunie, G. Rose, 2014, The Journal of Rheumatology.

‘In One Ear and Out the Other - It's a Lot to Take in’: A Qualitative Study Exploring the Informational Needs of Patients with ANCA-Associated Vasculitis:The Informational Needs of Patients with AAV

F. Poland, D. Scott, N. Spalding, 2013 .

Evaluation of the Sørensen diagnostic criteria in the classification of systemic vasculitis.

R A Watts, D. Scott, R. Watts, 2002, Rheumatology.

Epidemiology of vasculitis

D. Scott, R. Watts, 2002 .

ABC of Rheumatology: RASHES AND VASCULITIS

D. Scott, R. Watts, 1995, BMJ.

Educating people with rare rheumatological conditions.

R. Watts, J. Mooney, 2017, Rheumatology.

Educating people with rare rheumatological conditions Patients deserve better

R. Watts, J. Mooney, 2017 .

Refractory rheumatoid vasculitis—a therapeutic dilemma

R. Watts, E. Ntatsaki, 2016, Oxford medical case reports.

Modern management of primary systemic vasculitis.

D. Scott, R. Watts, C. Lapraik, 2007, Clinical medicine.

2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

P. Merkel, A. Judge, J. Robson, 2022, Arthritis & rheumatology.

Oxford Desk Reference Rheumatology

T. Marshall, R. Watts, G. Clunie, 2009 .

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population

A. Macgregor, R. Watts, M. Yates, 2016, BMC Musculoskeletal Disorders.

043. The Prevalence of Giant Cell Arteritis and Polymyalgia Rheumatica in a UK Primary Care Population

A. Macgregor, R. Watts, M. Yates, 2015 .

American College of Rheumatology and European League Against Rheumatism 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis

Catherine M. McGrath, P. Lanyon, R. Watts, 2017 .

The global burden of anti-neutrophil cytoplasmic antibody vasculitis: High but unquantified.

J. Robson, R. Watts, F. Pearce, 2016, Rheumatology.

083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS

P. Merkel, L. Moreland, K. Maksimowicz-McKinnon, 2019, Rheumatology.

Giant Cell Arteritis Presenting as Limb Claudication

A. Bhalla, R. Watts, M. Coppen, 1989, Journal of the Royal Society of Medicine.

EULAR recommendations for the management of primary small and medium vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the Rheumatic Diseases.

077. CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS

P. Merkel, A. Judge, J. Robson, 2019, Rheumatology.

Fat necrosis. An unusual cause of polyarthritis.

B. Hazleman, R. Watts, J. Hacking, 1993, The Journal of rheumatology.

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

K. Chakravarty, D. Scott, D. D'cruz, 2007, Rheumatology.

Treatment of Paget's disease of bone with single dose intravenous pamidronate.

R. Watts, S. Skingle, A. Crisp, 1994, Annals of the Rheumatic Diseases.

Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study

R. Moots, P. Salkovskis, Yulia Goryachev, 2012 .

Treatment of Paget's disease of bone with single dose intravenous pamidronate.

R. Watts, S. Skingle, A. Crisp, 1993, Seminars in arthritis and rheumatism.

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

P. Merkel, J. Stone, D. Scott, 2013, Arthritis and rheumatism.

EULAR recommendations for the management of large vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the rheumatic diseases.

Retrocalcaneal bursitis in polymyalgia rheumatica

W. Koldingsnes, M. Gonzalez-gay, G. Bentham, 2001, Annals of the rheumatic diseases.

Contrasting genetic association of IL2RA with SLE and ANCA – associated vasculitis

Kenneth G. C. Smith, J. Todd, M. Clatworthy, 2009, BMC Medical Genetics.

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

I. Bruce, D. Symmons, P. Macfarlane, 2019, Arthritis & Rheumatology.

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

V. Tesar, A. Vaglio, B. Crestani, 2016, Annals of the rheumatic diseases.

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

K. Chakravarty, D. D'cruz, R. Luqmani, 2007, Rheumatology.

Vasculitis in Clinical Practice

D. Scott, R. Watts, C. Mukhtyar, 2015 .

EULAR recommendations for the management of primary small and medium vessel vasculitis

H. Raspe, C. Kallenberg, David Steven Scott, 2008, Annals of the rheumatic diseases.

HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.

S. Mackie, A. Macgregor, R. Watts, 2015, Rheumatology.

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

I. Bruce, D. Symmons, P. Macfarlane, 2019, Arthritis & Rheumatology (Hoboken, N.j.).

Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

N. Basu, A. Mahr, L. Flores-Suárez, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

V. Tesar, A. Vaglio, B. Crestani, 2017, RMD Open.

Vasculitis syndromes: Inducing remission in ANCA-positive vasculitis: time to RAVE?

R. Watts, 2010, Nature Reviews Rheumatology.

SAT0216 PATIENT PERCEPTIONS OF PHYSICAL ACTIVITY AFTER A DIAGNOSIS OF GIANT CELL ARTERITIS: A SECONDARY ANALYSIS OF MULTINATIONAL QUALITATIVE DATA

C. Hill, S. Mackie, J. Robson, 2019, Saturday, 15 June 2019.

Classification and epidemiology of vasculitis: Emerging concepts.

R. Watts, Tegwen Ecclestone, 2023, Best practice & research. Clinical rheumatology.

338. HLA-DPB Alleles and Granulomatosis with Polyangiitis

S. Mackie, A. Macgregor, R. Watts, 2014 .

Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.

P. Mathieson, R. Watts, D. Peat, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care

T. Spector, D. Lawlor, D. Ray, 2013 .

Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020

C. Beadsmoore, R. Watts, C. Mukhtyar, 2023, Annals of the Rheumatic Diseases.

Increased risk of cardiovascular events with coxibs and NSAIDs

D. Scott, R. Watts, 2005, The Lancet.